Capital One Financial analyst Naureen Quibria has reiterated their bullish stance on FENC stock, giving a Buy rating today. Naureen Quibria’s rating is based on several key observations that highlight ...
In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on Fennec Pharmaceuticals (FENC – Research Report). The company’s shares closed last Friday at $5.76.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results